University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Lee-May Chen

Lee-May Chen, M.D.

Gynecologic cancer specialist

Dr. Lee-may Chen is a cancer expert specializing in gynecologic malignancies and an assistant clinical professor at the University of California, San Francisco. Chen has a particular interest in surgical and medical management of ovarian cancer. Her research focuses on early detection in women who are at a high risk of developing gynecological cancer, symptom management and decision-making in the treatment of gynecologic cancers. She earned her medical degree and completed her obstetrical and gynecological residency at the University of Michigan. She completed a fellowship in gynecologic oncology at UCLA Medical Center before joining UCSF Medical Center in 1999.

Conditions & Treatments

Clinics

Cancer Risk Program
1600 Divisadero St., Second Floor
San Francisco, CA 94143-1714
Phone: (415) 885-7779
Fax: (415) 885-3787

Hours: Monday to Friday
9 a.m. – 5 p.m.

Gynecologic Surgical Oncology
1600 Divisadero St., Fourth Floor
San Francisco, CA 94115
Phone: (415) 353-9600
New Patient Fax: (415) 353-7657

Hours: Monday to Friday
8 a.m. – 5 p.m.

More about Lee-May Chen

Additional Languages

Mandarin

Education

University of Michigan School of Medicine 1992

Residencies

University of Michigan Medical Center, Obstetrics and Gynecology 1996

Fellowships

UCLA and Cedar Sinai Medical Center, Gynecologic Oncology 1999

Selected Research and Publications

  1. Kaye SB, Lubinski J, Matulonis U, Ang JE, Gourley C, Karlan BY, Amnon A, Bell-McGuinn KM, Chen LM, Friedlander M, Safra T, Vergote I, Wickens M, Lowe ES, Carmichael J, Kaufman B. Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer. J Clin Oncol. 2012 Feb 1; 30(4):372-9.
  2. Ruskin R, Urban RR, Sherman AE, Chen LL, Powell CB, Burkhardt DH, Chen LM. Predictors of intensive care unit utilization in gynecologic oncology surgery. Int J Gynecol Cancer. 2011 Nov; 21(8):1336-42.
  3. Yang KY, Caughey AB, Little SE, Cheung MK, Chen LM. A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families. Fam Cancer. 2011 Sep; 10(3):535-43.
  4. Powell CB, Chen LM, McLennan J, Crawford B, Zaloudek C, Rabban JT, Moore DH, Ziegler J. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer. 2011 Jul; 21(5):846-51.
  5. Casey C, Chen LM, Rabow MW. Symptom management in gynecologic malignancies. Expert Rev Anticancer Ther. 2011 Jul; 11(7):1077-89.
  6. Chapman JS, Powell CB, McLennan J, Crawford B, Mak J, Stewart N, Chen LM. Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers. Gynecol Oncol. 2011 Aug; 122(2):339-43.
  7. Gupta D, Gunter MJ, Yang K, Lee S, Zuckerwise L, Chen LM, Goldberg GL, Huang GS. Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinoma. Int J Gynecol Cancer. 2011 Apr; 21(3):529-34.
  8. Rabban JT, Mackey A, Powell CB, Crawford B, Zaloudek CJ, Chen LM. Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation. Gynecol Oncol. 2011 Jun 1; 121(3):466-71.
  9. Chan JK, Sherman AE, Kapp DS, Zhang R, Osann KE, Maxwell L, Chen LM, Deshmukh H. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol. 2011 Mar 1; 29(7):832-8.
  10. Morgan RJ, Alvarez RD, Armstrong DK, Boston B, Burger RA, Chen LM, Copeland L, Crispens MA, Gershenson D, Gray HJ, Grigsby PW, Hakam A, Havrilesky LJ, Johnston C, Lele S, Matulonis UA, O'Malley DM, Penson RT, Remmenga SW, Sabbatini P, Schilder RJ, Schink JC, Teng N, Werner TL. NCCN Clinical Practice Guidelines in Oncology: epithelial ovarian cancer. J Natl Compr Canc Netw. 2011 Jan; 9(1):82-113.
  11. Nabilsi NH, Broaddus RR, McCampbell AS, Lu KH, Lynch HT, Chen LM, Loose DS. Sex hormone regulation of survivin gene expression. J Endocrinol. 2010 Nov; 207(2):237-43.
  12. Lester FC, Farmer DL, Rabban JT, Chen LM. Radical trachelectomy for clear cell carcinoma of the cervix in a 6-year old: a case report, review, and description of the surgical technique. J Pediatr Surg. 2010 Aug; 45(8):E1-5.
  13. Cohen JG, Kapp DS, Shin JY, Urban R, Sherman AE, Chen LM, Osann K, Chan JK. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol. 2010 Oct; 203(4):347.e1-6.
  14. Hirata H, Hinoda Y, Zaman MS, Chen Y, Ueno K, Majid S, Tripsas C, Rubin M, Chen LM, Dahiya R. Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancer. Carcinogenesis. 2010 Sep; 31(9):1620-6.
  15. Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Am J Surg Pathol. 2009 Dec; 33(12):1878-85.
  16. Chen LM, Weinberg VK, Chen C, Powell CB, Chen LL, Chan JK, Burkhardt DH. Perioperative outcomes comparing patient controlled epidural versus intravenous analgesia in gynecologic oncology surgery. Gynecol Oncol. 2009 Dec; 115(3):357-61.
  17. Chien AJ, Illi JA, Ko AH, Korn WM, Fong L, Chen LM, Kashani-Sabet M, Ryan CJ, Rosenberg JE, Dubey S, Small EJ, Jahan TM, Hylton NM, Yeh BM, Huang Y, Koch KM, Moasser MM. A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies. Clin Cancer Res. 2009 Sep 1; 15(17):5569-75.
  18. Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Am J Surg Pathol. 2009 Aug; 33(8):1125-36.
  19. McLemore MR, Miaskowski C, Aouizerat BE, Chen LM, Dodd MJ. Epidemiological and genetic factors associated with ovarian cancer. Cancer Nurs. 2009 Jul-Aug; 32(4):281-8; quiz 289-90.
  20. Kim DH, Wang-Chesebro A, Weinberg V, Pouliot J, Chen LM, Speight J, Littell R, Hsu IC. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up. Int J Radiat Oncol Biol Phys. 2009 Dec 1; 75(5):1329-34.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2012 The Regents of The University of California